Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on March 2000 and is headquartered in West Conshohocken, PA.
Market Cap
$6.85B
P/E Ratio
-12.53
1Y Stock Return
66.72%
1Y Revenue Growth
0.00%
Dividend Yield
0.00%
Price to Book
8.8
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive edge.
Yahoo
Insights into the Investment Shifts of a Hedge Fund Titan
Yahoo
There's a bright future ahead for this company.
Yahoo
The United States market has shown robust performance, rising 2.3% over the last week and 35% over the past year, with earnings forecasted to grow by 15% annually. In this thriving environment, a good stock often combines strong growth potential with innovative technology solutions that align well with current market trends and future growth expectations.
Yahoo
CONSHOHOCKEN, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences: UBS Global Healthcare Conference 2024Wednesday, November 13, 2024 at 2:00 P.M. ESTThe presentation will be webcast live and may be accessed here. 7th Annual Evercore HealthCONx ConferenceWednesday, December 4, 2024 at 9:35 A.M. EST Piper Sandler 36th Annual Healthcare ConferenceThursday, Dece
Yahoo
Novo's Rival Drug Shows Promise, But Madrigal's First-Mover Advantage Keeps Investors Hooked--What's Next for This Rising Star?
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SOLV | -0.06% | $11.58B | -16.19% | 0.00% |
BACK | 0.06% | $1.76M | -32.90% | 0.00% |
PFG | -0.10% | $19.25B | +16.58% | 3.30% |
CRCT | 0.12% | $1.12B | -19.90% | 1.91% |
NNVC | -0.13% | $19.66M | +25.69% | 0.00% |
EB | 0.15% | $341.99M | -48.62% | 0.00% |
FWONA | 0.18% | $18.48B | +27.70% | 0.00% |
RDDT | -0.22% | $24.08B | +303.41% | 0.00% |
ARIS | 0.23% | $763.08M | +214.02% | 1.56% |
BALL | 0.23% | $17.88B | +11.46% | 1.34% |
TSM | -0.25% | $983.61B | +92.73% | 1.17% |
OXBR | 0.29% | $19.05M | +178.18% | 0.00% |
CORZ | 0.30% | $4.60B | +3,201.26% | 0.00% |
CHD | 0.33% | $27.18B | +19.50% | 1.03% |
CHDN | 0.35% | $10.20B | +15.49% | 0.28% |
RSG | -0.37% | $66.05B | +31.79% | 1.04% |
LTM | 0.48% | $8.51B | -100.00% | <0.01% |
NAT | 0.52% | $636.83M | -30.05% | 13.79% |
ADBE | 0.55% | $219.93B | -18.23% | 0.00% |
EGHT | 0.58% | $351.48M | -7.88% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TILE | 36.56% | $1.45B | +150.00% | 0.16% |
AKRO | 35.42% | $2.17B | +93.09% | 0.00% |
FUN | 34.23% | $4.60B | -16.51% | 0.00% |
EYE | 33.79% | $888.30M | -42.18% | 0.00% |
CRSP | 33.34% | $4.01B | -30.49% | 0.00% |
BEAM | 32.43% | $2.09B | -9.52% | 0.00% |
CSV | 31.84% | $590.66M | +75.49% | 1.16% |
KALV | 31.19% | $440.88M | +17.08% | 0.00% |
ATEC | 31.01% | $1.36B | -16.49% | 0.00% |
CRNX | 30.63% | $5.12B | +84.27% | 0.00% |
FOLD | 30.49% | $2.84B | -11.52% | 0.00% |
AMSC | 30.30% | $1.25B | +257.53% | 0.00% |
EDIT | 30.30% | $204.72M | -75.49% | 0.00% |
PRKS | 30.18% | $3.08B | +14.79% | 0.00% |
LAND | 30.15% | $433.13M | -17.05% | 4.30% |
ACLX | 30.03% | $4.74B | +69.19% | 0.00% |
ABG | 29.81% | $4.91B | +21.76% | 0.00% |
HASI | 29.81% | $3.29B | +16.65% | 5.90% |
RCKT | 29.80% | $1.20B | -39.83% | 0.00% |
WNC | 29.79% | $804.33M | -13.95% | 1.72% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ANIK | -17.24% | $249.56M | -17.52% | 0.00% |
HII | -16.52% | $7.50B | -19.92% | 2.70% |
TH | -15.84% | $839.02M | -24.49% | 0.00% |
PULM | -15.73% | $19.83M | +202.98% | 0.00% |
ACGL | -15.71% | $36.00B | +16.84% | 0.00% |
ESNT | -13.76% | $5.93B | +16.81% | 1.96% |
MGPI | -13.04% | $1.02B | -48.95% | 1.04% |
AFL | -12.77% | $61.74B | +35.69% | 1.35% |
VRN | -12.22% | $3.23B | -25.43% | 6.21% |
SNN | -12.17% | $11.12B | -0.04% | 2.98% |
HUSA | -12.14% | $16.69M | -11.56% | 0.00% |
NOC | -11.76% | $71.54B | +4.23% | 1.60% |
TPST | -11.67% | $37.75M | -77.59% | 0.00% |
GEL | -11.09% | $1.44B | +2.81% | 5.24% |
TXO | -11.09% | $737.26M | -1.80% | 13.22% |
DK | -10.83% | $1.14B | -34.04% | 5.64% |
ACHC | -10.59% | $3.45B | -48.91% | 0.00% |
OTEX | -10.05% | $7.59B | -26.30% | 3.55% |
SMC | -10.00% | $383.35M | +97.26% | 0.00% |
GAN | -9.98% | $83.39M | +21.19% | 0.00% |
Current Value
$315.751 Year Return
Current Value
$315.751 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -20.46% | $388.04M | 1.43% |
UUP | -14.11% | $309.25M | 0.77% |
DBA | -13.68% | $755.88M | 0.93% |
USDU | -13.56% | $201.97M | 0.5% |
VIXY | -11.56% | $195.31M | 0.85% |
EQLS | -9.50% | $76.08M | 1% |
KMLM | -9.40% | $353.87M | 0.9% |
DBO | -9.10% | $217.57M | 0.77% |
USCI | -7.31% | $185.47M | 1.07% |
FMF | -7.31% | $244.61M | 0.95% |
TAIL | -6.83% | $67.98M | 0.59% |
CTA | -5.48% | $350.27M | 0.78% |
IBTE | -5.30% | $1.70B | 0.07% |
DBE | -5.20% | $50.13M | 0.77% |
CLOI | -5.07% | $715.40M | 0.4% |
GSG | -4.50% | $914.42M | 0.75% |
COMT | -4.32% | $829.06M | 0.48% |
DBMF | -3.76% | $1.02B | 0.85% |
HIGH | -3.27% | $302.78M | 0.51% |
KRBN | -2.49% | $242.47M | 0.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBIL | -0.08% | $637.70M | 0.15% |
KCCA | 0.11% | $220.51M | 0.87% |
ULST | 0.16% | $535.47M | 0.2% |
SOYB | -0.17% | $27.32M | 0.22% |
CCOR | -0.42% | $109.04M | 1.18% |
FTGC | -0.50% | $2.17B | 1.02% |
XHLF | -0.57% | $874.27M | 0.03% |
DBC | -0.61% | $1.39B | 0.87% |
MINT | -0.83% | $11.62B | 0.35% |
JUCY | -1.10% | $324.29M | 0.6% |
CORN | 1.22% | $61.12M | 0.2% |
DUSB | -1.23% | $797.63M | 0.15% |
GCC | 1.28% | $133.23M | 0.55% |
BOXX | -1.61% | $4.43B | 0.1949% |
BILZ | 1.68% | $563.02M | 0.14% |
SGOV | 1.73% | $27.53B | 0.09% |
BCI | 1.99% | $1.20B | 0.26% |
TBIL | -2.06% | $4.38B | 0.15% |
PDBC | -2.09% | $4.40B | 0.59% |
BCD | 2.28% | $245.02M | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 42.39% | $6.58B | 0.35% |
RSPA | 40.06% | $273.87M | 0% |
PTH | 38.01% | $143.31M | 0.6% |
IBB | 37.75% | $6.66B | 0.45% |
GNOM | 34.19% | $70.59M | 0.5% |
FBT | 33.47% | $1.11B | 0.56% |
BBH | 32.06% | $397.87M | 0.35% |
PBE | 31.93% | $258.53M | 0.58% |
SMMV | 31.61% | $321.07M | 0.2% |
QQQJ | 31.06% | $698.04M | 0.15% |
VIOV | 31.01% | $1.44B | 0.15% |
IJR | 30.97% | $90.05B | 0.06% |
IZRL | 30.94% | $102.75M | 0.49% |
AOM | 30.77% | $1.43B | 0.15% |
VB | 30.71% | $63.63B | 0.05% |
ARKK | 30.60% | $6.28B | 0.75% |
QQA | 30.55% | $135.01M | 0% |
EFAA | 30.52% | $117.38M | 0% |
ARKG | 29.91% | $1.13B | 0.75% |
XPH | 28.97% | $157.87M | 0.35% |